) How might the drug pricing reforms impact pharmaceutical companies' ability to invest in research and development, and what potential consequences could this have on the development of new life-saving medicines? b) What strategies can the pharmaceutical industry employ to challenge or circumvent the drug pricing reforms, and how might these legal battles affect the implementation and effectiveness of the reforms in the long term? c) Beyond the financial aspects, what broader implications might these drug pricing reforms have on the global pharmaceutical industry, innovation in healthcare, and access to affordable medications in other countries, considering the substantial influence of the U.S. pharmaceutical market